South Africa: The First Generic Weight Loss Drug Hit South Africa In August - With Many Expected To Follow. Will It Be Enough To Kill The Black Market?

South Africa's first generic semaglutide injection entered the market in August, with additional generics anticipated to join the market soon. This increased competition is expected to lower the price of the high-demand GLP-1 drugs; however, it remains to be seen if they will be affordable enough to eliminate the thriving black market and benefit the public-sector patients in need.

GLP-1 drugs, originally developed for diabetes treatment, have become popular as weight-loss solutions. The GLP-1 market is projected to reach $190-billion by 2035, a significant increase from its 2025 value. While these drugs offer promising results, their high cost poses a significant challenge, especially for those with limited financial resources.

In South Africa, the generic semaglutide injection, launched by Sun Pharma, aims to address the high prices and provide a more affordable option for patients. However, the success of generics in combating the black market and reaching those who require the medication most remains uncertain.